Glycomics/Glycobiology Market Size to Reach USD 2.88 Billion in 2028; rising demand for precision medicine are some other key factors expected to drive market revenue growth over the forecast period, Says Reports And Data

·6 min read

Major companies operating in the market include Thermo Fisher Scientific, Inc. Merck KGaA, Agilent Technologies Bruker Corporation, New England Biolabs, Danaher, Shimadzu Corporation, Takara Bio, Inc., Asparia Glycomics S.L, and ProZyme.

New York, May 11, 2021 (GLOBE NEWSWIRE) -- Increasing use of informatics in glycobiology-based research, development of well-defined glycan microarrays, and technological advancements that have enabled in-depth study of glycans are key factors driving market growth

Market Size – USD 1.0 Billion in 2020, Market Growth – at a CAGR of 14.1%, Market Trends – Emerging potential of glycomics in biomarker research

The global glycomics/glycobiology market size is expected to reach USD 2.88 Billion in 2028 at a CAGR of 14.1%, according to the latest report by Reports and Data. Growing focus on glycomics and proteomics research, rising R&D expenditure, technological advancements in glycomics instruments, and increasing application of glycomics in immunology, biochemistry, and oncology are key factors expected to drive market revenue growth over the forecast period. Rapid expansion of biotechnology and pharmaceutical sectors across the globe, increasing application of glycomics in drug discovery and development, and rising demand for precision medicine are some other key factors expected to drive market revenue growth over the forecast period.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3986

Glycans, which are sequences of carbohydrates conjugated to lipids and proteins, are the most abundant and structurally disparate class of molecules. Glycomics or glycobiology is the study of structure, biology, and function of these glycans in any cell or organism. Glycomics also focuses on the genetic, physiologic, and pathologic aspects of glycans. Recent advancements in glycomics research has helped researchers and scientists understand the scope and scale of glycans’ functional roles and their impact in disease condition in humans. This is expected to contribute significantly to revenue growth of the market going ahead. Glycoproteins and glycolipids found at the cell membrane form a carbohydrate-coated surface which facilitates communication of cells with extracellular environment. These interactions with the cell-surface oligosaccharides play a vital role in various critical biological events such as cell differentiation, cellular adhesion, immune responses, and host-pathogen interactions.

Glycomics is an integral part of microbiology research as glycans have various roles in bacterial physiology. Extensive research in bacterial glycomics has resulted in rapid development of novel drugs, bioactive glycans, and glycoconjugate vaccines. Increasing application of glycomics in drug discovery and development and precision medicine are key factors expected to drive market growth over the forecast period. Glycans released from blood or tissue proteins provide a crucial source of biomarkers and hence, glycomics has the potential to revolutionize biomarker discovery and this is expected to further contribute to revenue growth of the market over the forecast period.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/glycomics-glycobiology-market

Some Key Highlights from the Report:

  • Glycosidases are extensively studied in oncology research owing to their capability to alter N-linked glycans which contribute to metastatic and neoplastic properties of tumor cells. This has boosted the use of enzymes in cancer research and diagnostics and this is expected to contribute to revenue growth of the enzymes segment.

  • Drug discovery and development segment is expected to register significant revenue growth over the forecast period owing to increasing demand for glycomics products in drug research, growing investment in biopharmaceutical R&D activities, rising demand for precision medicine, and emerging potential of glycomics in biomarker discovery.

  • Academic & research institutes segment is expected to account for largest revenue share in the global market over the forecast period attributable to rising investment in proteomics and glycomics research, increasing collaborations between research institutions and key companies, and rising application of glycomics research in biomedical and biochemistry research.

  • Asia Pacific is expected to register rapid revenue CAGR over the forecast period owing to rapid growth of biopharmaceutical sector, growing investment in CROs, increasing drug research and development, and rising government and private funding for proteomics and glycomics research.

  • In April 2021, BridgeBio Pharma, Inc., and Canadian Glycomics Network (GlycoNet) announced a strategic collaboration that aims to identify and translate scientific research programs in glycomics that have the potential to become therapeutic approaches for genetic diseases.

Major companies operating in the market include:

  • Thermo Fisher Scientific, Inc.

  • Merck KGaA

  • Agilent Technologies Bruker Corporation

  • New England Biolabs

  • Danaher

  • Shimadzu Corporation

  • Takara Bio, Inc.

  • Asparia Glycomics S.L

  • ProZyme

Order Now: https://www.reportsanddata.com/checkout-form/3986

For the purpose of this report, Reports and Data has segmented the global glycomics/glycobiology market based on, product, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2018-2028)

  • Enzymes

    • Glycosidases & Neuramidases

    • Glycosyltransferases & Sialytransferases

    • Others

  • Instruments

    • Mass Spectrometry Instruments

    • Chromatography Instruments

    • Arrays

    • Others

  • Kits

    • Glycan Releasing Kits

    • Glycan Labelling Kits

    • Glycan Purification Kits

    • Others

  • Reagents

Application Outlook (Revenue, USD Billion; 2018-2028)

  • Drug Discovery & Development

  • Diagnostics

  • Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Academic Research Institutes

  • Pharmaceutical and Biotechnology Companies

  • CROs

  • Others

Regional Outlook (Revenue, USD Billion; 2018-2028)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • U.K.

    • Italy

    • France

    • BENELUX

    • Rest of Europe

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of APAC

  • Latin America

    • Brazil

    • Rest of LATAM

  • Middle East & Africa

    • Saudi Arabia

    • U.A.E.

    • South Africa

    • Rest of MEA

Browse similar research reports:

Blood Preparation Market Size, Share & Analysis, By Product Type (Whole Blood, Blood Components, Blood Derivatives), By Antithrombotic And Anticoagulant Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), By Application (Angina Blood Vessel Complications, Pulmonary Embolism, Thrombocytosis, Renal Impairment, Others), And By Region, Forecast To 2028

Live Cell Encapsulation Market Size, Share & Analysis, By Technique (Simple Dripping, Electrostatic Dripping, Liquid Jet Break Up, Coaxial Airflow, Vibrating Jet, Jet Cutting), By Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate, HEMA-MMA, PAN-PVC, Others), By Application (Regenerative Medicine, Probiotics, Cell Transplantation, Drug Delivery, Research) And Region, Forecast To 2028

Multiplex Assays Market Size, Share And Analysis, By Product (Consumables, Instruments, Software & Services), Type (Nucleic Acid Assay, Protein Assay, Cell-Based Assay), Technology (Flow Cytometry, Luminescence, Fluorescence Detection, Multiplex RT-PCR, Other Technologies), Application (Research & Development, Clinical Diagnostics, Other Diseases), End Use (Pharmaceutical & Biotechnology Companies, Reference Laboratory, Hospitals & Academic Research Institutes, Reference Laboratories), And By Region To 2028

Peptide Synthesis Market Size, Share & Analysis, By Product (Reagent, Synthesizer, Chromatography), Technology (Solid Phase, Liquid Phase, And Hybrid & Recombinant), End User (Pharmaceuticals & Biotechnology, CRO), And Region Forecast To 2028

Immunofluorescence Assay (IFA) Market Size, Share & Analysis, By Products (Antibodies, Reagents, Kits, Instruments, Consumables & Accessories), By Type (Indirect, Direct), By Disease (Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Others), By End-use Industry (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, CROs, Hospitals & Diagnostic Centers), By Region, Forecast To 2028


About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-glycomics-glycobiology-market


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting